Oxaliplatin-induced Peripheral Neuropathy
📧 Sign up to get email alerts when something new happens for Oxaliplatin-induced Peripheral Neuropathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-20Clinical Trial Update: The Effect of Electrostimulation and Compression Applications on Neuropathy Symptoms and Quality of Life in the Management of Chemotherapy-Induced Peripheral Neuropathy in Gastrointestinal System Cancer Patients Receiving Oxaliplatin-Based Treatment [NA]
Completed clinical trial evaluating whether electrostimulation and compression can reduce chemotherapy-induced peripheral neuropathy symptom…
-
CLINICAL_TRIALS trial_result · 2024-12-10Clinical Trial Update: Ultrasound Acupuncture for Oxaliplatin-induced Peripheral Neuropathy in Colorectal Cancer Patients [NA]
A clinical trial evaluating ultrasound acupuncture for oxaliplatin-induced peripheral neuropathy in colorectal cancer patients has completed…
-
CLINICAL_TRIALS trial_result · 2023-05-23Clinical Trial Update: Effect of Lidocaine Transdermal Patch as Add-On Therapy in Treatment of Oxaliplatin Induced Peripheral Neuropathy in Colorectal Cancer Patients [Phase 2]
Phase 2 clinical trial evaluating a lidocaine transdermal patch as add-on therapy for oxaliplatin-induced peripheral neuropathy in colorecta…
-
CLINICAL_TRIALS trial_result · 2017-05-09Clinical Trial Update: Evaluate The Efficacy and Safety Of Pregabalin In Prevention, Reduction of Oxaliplatin-Induced Painful Neuropathy [Phase 3]
A Phase 3 clinical trial evaluated pregabalin for the prevention and reduction of oxaliplatin-induced painful peripheral neuropathy; the stu…
-
CLINICAL_TRIALS trial_result · 2015-12-02Clinical Trial Update: Estimate the Efficacy of HD6610 Granule for Oxaliplatin-induced Peripheral Neuropathy [Phase 2, Phase 3]
A clinical trial update evaluating the efficacy of HD6610 Granule for oxaliplatin-induced peripheral neuropathy in Phase 2 and Phase 3.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.